Evidence Hub

Fatal Disseminated Varicella-Zoster Virus in an Immunocompetent Woman

Donnan M, Selvarajah J, Ho HK, Fung A

Cureus, 2024

Abstract

Disseminated herpes zoster (DHZ), caused by the reactivation of latent varicella-zoster virus (VZV), is usually a condition that affects the immunocompromised population. It is uncommon in a vaccinated population. A previously well, independent 91-year-old lady with no known immunosuppressing conditions presented to the hospital with a productive cough and new confusion. Several days into her admission, she developed a cutaneous maculopapular rash, and then symptoms of headache and seizures, followed by a coma. This coincided with the development of extensive neuroimaging findings, including widespread vasogenic edema and mass effect. Despite treatment with intravenous antiviral therapy, she deteriorated and passed away, with a retrospective diagnosis of DHZ. This case illustrates rapid progression of VZV infection and potential for fatality in elderly, unvaccinated but immunocompetent individuals. It provides a reminder of the importance of maintaining a degree of clinical suspicion for the diagnosis of DHZ in those with suggestive features, especially in unvaccinated individuals.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free